“Rather than say using invasive approaches… blood samples like plasma or serum capture the signature of a cancer somewhere in the body… In many cases we can detect those signatures up to 7 years before [a #cancer diagnosis].” – Dr. Philip Awadalla, Director at OICR
Registration for the next CanPath trainee research webinar is live! Join @mp_harwood and Umaimah Zanif as they showcase how CanPath data can be used to explore how age, lifestyle factors, and the environment affect gene and biomarker expression.
https://t.co/Cu99QUBaXw
Congratulations, @NancyGenetics! From Scientific Director @AwadallaLab, "Nancy has been an instrumental advisor on CanPath's Int'l Scientific Advisory Board. Her impact as a researcher and leadership as a geneticist have been a cornerstone to CanPath's success on a global scale."
@RadvanyiLaszlo Well done Nick from @AwadallaLab!!! Great work describing the utility of @ON_HealthStudy and @CanPath in developing early detection liquid biopsies for #breastcancer from pre-diagnostic samples many years before diagnosis and in some cases mammography.
OHS participant Matt asks: How does our blood change as we age?
Find out from cancer researcher Dr. @KimSkead how our blood acts as an early messenger of emerging health issues, and why platforms like the OHS are important to the early detection of cancer & chronic disease.
Congratulations to @mp_harwood for the successful defence of a superb dissertation describing the evolutionary and functional forces driving allele specific expression variation in @CanPath!
Panel Discussion: Chairs @HeidiRehm & @PersonalizedMed lead a discussion at @AGBT Precision Health 2023 with polls on the great debate, genetics, environment & health with @GaryWMiller3 from @Columbia, @AwadallaLab from @CanPath & Alison Motsinger-Reif from @NIEHS#AGBTPH
Don't miss The Great Debate!
Join us for a once-in-a-generation conversation about the root causes of genetic mutations. You won't want to miss this!
Register for AGBT Precision Health 2023 today: https://t.co/ajVu3YtOCv
🔬🦠 Boosting Immunity Insights: New research led by @COVIDimmunityTF, with contributions from CanPath, reveals Canada's evolving immunity landscape in the first pan-Canadian seroprevalence study!
🔗 https://t.co/h4VKx9Cd1v
Working with @AwadallaLab at OICR helped @UofT PhD candidate Tom Ouellette turn an interest in computational biology into a passion for #research that impacts #cancer patients
See what Tom's working on in our latest The Next Generation video📽️
The Next Generation: @nickwfcheng, PhD candidate in @AwadallaLab, is using OHS & @CanPath data to look for #biomarkers in the blood that could be used to detect breast, prostate and pancreatic cancers several years before a traditional diagnosis.
https://t.co/mXaDkMb08H
📢 Our COVID-19 Antibody Study found that 53% of the #COVID19 diagnoses were among those who neither knew, nor suspected, they had been infected! Check out Dr. Victoria Kirsh’s findings in her @CanPath webinar. @AwadallaLab@KimSkead
https://t.co/DN2E61oqLa
Huge congratulations to Dr. @KimSkead who passed her viva for her fantastic dissertation “Predicting health outcomes from hematopoietic evolution”!! Thanks to our external examiner @jrblundell, and @wilson_md@stepheniwright@fgaiti and Lucy Osborne!
🎥 Discover the latest insights on COVID-19 vaccines and risk factors from our recorded event, from undetected COVID-19 cases to vaccine effectiveness against Omicron and the protection offered by prior infection. 📺 https://t.co/yyEoaGjYx5
A recent @NatureComms paper by @inofechm, Dr. @david_soave, Dr. Philip Awadalla (@AwadallaLab) and Dr. Sagi Abelson has been selected as an Editors' Highlight. 👏
https://t.co/26snZfrmm1
🔍 Ever wondered how time since vaccination affects your protection against #COVID19? 🤔 Register for our event on May 30th with Dr. Victoria Kirsh, where she will present the latest findings from the SUPPORT-Canada study: https://t.co/MKWVUj6UJe